Überprüfung…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen
Homepage / Eingetragen in Nigeria / Paracetamol Injection 300 mg/2 mL_

Paracetamol Injection 300 mg/2 mL_

NAFDAC Reg.-Nr. A4-101373 Medikament

Registriert bei NAFDAC. Registrierung aktivAs of 1 November 2026 · synced automatically from official sources.
Produkt-
Paracetamol Injection 300 mg/2 mL_
NAFDAC-Nummer
A4-101373
Wirkstoff
Paracetamol
Stärke
300 mg/2 mL
Form
Injection
VPE:
1 x 10 mL (in ampoules)
Hersteller
Nicht aufgeführt
Applicant (holder)
Grace Pharmacare Ltd
Approved
25 Jun 2025
Status
Active View on NAFDAC ↗
Registration valid to
24 Jun 2030
WER WARNT
None found
Community reports
None
Times checked
0
Commonly used to relieve mild to moderate pain and reduce fever. General information only — follow the dosage on the pack or your pharmacist's instructions.

About the medicine: Paracetamol: uses, dosage and brands worldwide

What we found

  • Paracetamol Injection 300 mg/2 mL_ is on the NAFDAC register with an active registration (A4-101373). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Paracetamol Injection 300 mg/2 mL_

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

How to take it and how often
  • Do not take more than directed
  • Adults and children 12 years and over take 2 gelcaps every 6 hours while symptoms last
  • Do not take more than 6 gelcaps in 24 hours, unless directed by a doctor
  • Do not take for more than 10 days unless directed by a doctor
  • Children under 12 years: ask a doctor
Talk to a doctor first if

liver disease.

Warnings

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take more than 4,000 mg of acetaminophen in 24 hours with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away. Do not use if you are allergic to acetaminophen or any of the inactive ingredients in this product with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. …

Possible side effects

New symptoms occur pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present These could be signs of a serious condition.

Pregnancy and breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

How to store it

Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) avoid high humidity see end flap for expiration date and lot number Keep out of reach of children.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-01-02.

Label for paracetamol, the active ingredient registered with NAFDAC.

NAFDAC recall & alert notices

Public Alert No. 10/2024 – Alert on the Sale of Falsified Mislabelled Paracetamol Injection Circulating in Nigeria15 Feb 2024 · nafdac.gov.ngThe National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of the sale of a falsified Paracetamol Injection mislabelled as  Paracetamol Injection 300mg/2ml I.M I.V Aminoglycoside Antibacterial. The product was discovered during a surveillance activity carried out by the post-mark…Public Alert No. 017/2023 – Alert on Substandard Paracetamol Suspension Received from Republic of Liberia12 Jun 2023 · nafdac.gov.ng, The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a substandard paracetamol suspension PARA CLEAR SUSPENSION 125 received from Liberian Medicine and Health Product Regulatory Authority for laboratory testing in the NAFDAC Central Drug Control Laboratory (CDCL). Labo…Public Alert No. 0023/2019 – Alert on Dangerous and Unapproved Use of Paracetamol Tablets in Food Preparation.29 Dec 2019 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) hereby alerts the public on the dangerous and unapproved use of Paracetamol Tablets to soften meat used in food preparation. NAFDAC is seriously concerned by social media publication on dangerous and illegal use of Paracetamol Tablets to tender…Public Alert 017/2018 – Alert On Withdrawal Of Medicines With Modified Or Prolonged Release Paracetamol By Portugal Internal Health Authority16 Jul 2018 · nafdac.gov.ngThe National Agency for Food and Drug Administration and Control (NAFDAC) has been informed that the Portuguese Authority for Medicines (INFARMED) on the 9th march, 2018 announced the suspension and withdrawal of medicines containing modified or prolonged-release paracetamol, following a safety assessment conducted by …

Compare the brands and batch numbers in these notices with your pack, or enter your batch number above.

Check your pack of Paracetamol Injection 300 mg/2 mL_

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Paracetamol Injection 300 mg/2 mL_

What is in Paracetamol Injection 300 mg/2 mL_?

Paracetamol Injection 300 mg/2 mL_ contains Paracetamol (300 mg/2 mL), as injection, according to its NAFDAC registration record.

Is Paracetamol Injection 300 mg/2 mL_ registered with NAFDAC?

Yes. Paracetamol Injection 300 mg/2 mL_ is listed on the NAFDAC register under registration number A4-101373, and its registration is active as of 1 November 2026.

Has Paracetamol Injection 300 mg/2 mL_ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Paracetamol Injection 300 mg/2 mL_ in our automatically synced alert list.

How can I check that my pack of Paracetamol Injection 300 mg/2 mL_ is genuine?

Run a free authenticity scan with the NAFDAC number A4-101373, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Paracetamol Injection 300 mg/2 mL_?

Follow your prescription or the leaflet in your pack. The official label says: do not take more than directed adults and children 12 years and over take 2 gelcaps every 6 hours while symptoms last do not take more than 6 gelcaps in 24 hours, unless directed by a doctor do not take for more than 10 days unless directed by a doctor children under 12 years: ask a doctor…

What is Paracetamol Injection 300 mg/2 mL_ used for?

temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever (Summarised from the official U.S. FDA label for paracetamol. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Paracetamol Injection 300 mg/2 mL_? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.